Tuesday, 4 July 2017
On 7/04/2017 04:52:00 pm by Suhani Varma in Accurate Stock Tips, best intraday tips provider, best stock tips, Equity Tips, Indian stock tips, intraday tips, Premium Equity Tips, Share advisory, Shares Tips, Stock Option, ways2cap Premium Equity Tips No comments

USFDA gives approval to Wockhardt for its ANDA (Abbreviated New Drug Application) for 0.1% ophthalmic solution of Olopatadine HCL, manufactured in Montreal, Canada, it is an eye drop and is a generic version of Patanol marketed in the US by Alcon, a subsidiary of Novartis.
Wockhardt Ltd is a biotechnology and pharmaceutical company, which is included manufacturing and marketing of biopharmaceuticalformulations and pharmaceutical, active pharmaceutical ingredient (APIs) and vaccines.
The company’s scrip opened at Rs 614.9 which had a Rs 615.3 and 610.05 of high and low, 63871 NSE+BSE share were traded on the counter and Rs 6689.63cr is a current market cap.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment